Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC., Parsnippany, NJ 07054. NDC: 67877-500-30
Published July 29, 2026 · Recall initiated: July 8, 2026
Summary
FDA records drug Class II recall D-0712-2026, published July 29, 2026 and initiated July 8, 2026. Recalling firm: Ascend Laboratories, LLC; Status: Ongoing; Reported quantity: 6,192 bottles; Lot: Lot 25121311, expiry 3/31/2028. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications
What to do
Voluntary: Firm initiated · Letter
Get an email if AMLODIPINE AND OLMESARTAN MEDOXOMIL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- AMLODIPINE AND OLMESARTAN MEDOXOMIL
- Manufacturer
- Ascend Laboratories, LLC
- Distributor
- Nationwide in the USA
- Lot
- Lot 25121311, expiry 3/31/2028
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAmlodipine and Olmesartan Medoxomil Tablets, 10mg/40mg, 30 Tablets, Rx only, Manufactured by: AlkemOctober 28, 2026
- FDALevothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 10 Tablets (10 x 1) unit dose blisters per carton, RxJuly 29, 2026
- FDALidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use Only, Rx Only,July 29, 2026
- FDAAmlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg, Rx Only, 30-count bottle, Manufactured by: AlkemJune 10, 2026
- FDAAmlodipine and Olmesartan Medoxomil Tablets, 5 mg/ 40 mg, 30-count bottle, Rx Only, Manufactured by: AlkemAugust 20, 2025
- FDAAmlodipine and Olmesartan Medoxomil Tablets, 10 mg /20 mg, 30-count bottles, Rx only, Manufactured for:March 9, 2022
Questions about this recall
Was Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC., Parsnippany, NJ 07054. NDC: 67877-500-30 recalled?
Yes. FDA published recall D-0712-2026 on July 29, 2026. Reported hazard: Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: AMLODIPINE AND OLMESARTAN MEDOXOMIL.